WGS of Korean Idiopathic Bronchiectasis (NCT03809091) | Clinical Trial Compass
UnknownNot Applicable
WGS of Korean Idiopathic Bronchiectasis
South Korea20 participantsStarted 2019-01
Plain-language summary
Whole genome sequencing of Korean patients with idiopathic bronchiectasis and their family will perform to identify disease-causing variants.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* If the patient has bronchiectasis proved by computed tomography (CT).
* The clinical features of the patient are suitable for ciliary dysfunction disease (primary ciliary dyskinesia, cystic fibrosis), alpha1-antitrypsin deficiency, and primary immune deficiency (hyper-immunoglobulin E syndrome, hypogammaglobulinemia, activated phosphoinositide 3-kinase (PI3K) delta syndrome, bare lymphocyte syndrome)
* The patient has no apparent medical events causing bronchiectasis.
Exclusion Criteria:
* If the patient does not agree or withdraw
* If the patient has any clear etiology causing bronchiectasis including AIDS, malignancy, receiving immunosuppressant or chemotherapy.
What they're measuring
1
Number of diagnosed patients by using whole genome sequencing